公开(公告)号：US11084842B2

公开(公告)日：2021-08-10

申请号：US16960488

申请日：2019-01-22

申请人： SUNSHINE LAKE PHARMA CO., LTD.

发明人： Zheng Gu ,  Wuyong Wu ,  Tong Qu ,  Panpan Kang ,  Zongyuan Zhang ,  Weiming Huang ,  Jianyu Liu ,  Yingjun Zhang

IPC分类号： C07H7/04 ,  C07H15/207

摘要： A glucopyranosyl derivative as a sodium-dependent glucose transporters inhibitor, especially as a SGLT1 inhibitor, a pharmaceutically acceptable salt or a stereoisomer thereof, a pharmaceutical composition thereof, and the uses of the compound and pharmaceutical composition thereof in the preparation of drugs for the treatment of diabetes and diabetes-related diseases.

公开(公告)号：US11186602B2

公开(公告)日：2021-11-30

申请号：US16965438

申请日：2019-01-29

申请人： SUNSHINE LAKE PHARMA CO., LTD.

发明人： Zheng Gu ,  Wuyong Wu ,  Panpan Kang ,  Tong Qu ,  Zongyuan Zhang ,  Weiming Huang ,  Tianyun Wu ,  Yingjun Zhang

IPC分类号： C07H9/04 ,  A61P3/10 ,  A61K31/7048 ,  A61K45/06

摘要： A glucopyranosyl derivative is used as an inhibitor of sodium-dependent glucose transporters (SGLTs), particularly being used as an inhibitor of sodium-dependent glucose transporter-1 (SGLT1), and a pharmaceutically acceptable salt or stereoisomer thereof, further relating to a pharmaceutical composition containing the derivative. The compound and a pharmaceutical composition is used thereof in the preparation of a drug for treating diabetes and diabetes-related diseases.